Zobrazeno 1 - 10
of 397
pro vyhledávání: '"van Wering, E"'
Autor:
van Wering, E R, van der Linden-Schrever, B E M, van der Velden, V H J, Szczepański, T, van Dongen, J J M, van der Linden-Schrever, B E (AUTHOR), van der Velden, V H (AUTHOR), Szczepański, T (AUTHOR), van Dongen, J J (AUTHOR)
Publikováno v:
Leukemia (08876924). Aug2001, Vol. 15 Issue 8, p1301-1303. 3p.
Autor:
Hubeek, I., Stam, R. W., Peters, G. J., Broekhuizen, R., Meijerink, J. P.P., Van Wering, E. R., Gibson, B. E.S., Creutzig, U., Zwaan, C. M., Cloos, J., Kuik, D. J., Pieters, R., Kaspers, G. J.L.
Publikováno v:
Hubeek, I, Stam, R W, Peters, G J, Broekhuizen, R, Meijerink, J P P, Van Wering, E R, Gibson, B E S, Creutzig, U, Zwaan, C M, Cloos, J, Kuik, D J, Pieters, R & Kaspers, G J L 2005, ' The human equilibrative nucleoside transporter I mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia ', British Journal of Cancer, vol. 93, no. 12, pp. 1388-1394 . https://doi.org/10.1038/sj.bjc.6602881
British Journal of Cancer, 93(12), 1388-1394. Nature Publishing Group
British Journal of Cancer, 93(12), 1388-1394. Nature Publishing Group
Cytarabine (ara-C) is the most effective agent for the treatment of acute myeloid leukaemia (AML). Aberrant expression of enzymes involved in the transport/metabolism of ara-C could explain drug resistance. We determined mRNA expression of these fact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::358cc418a50506f06813d98470a1a723
https://research.vumc.nl/en/publications/4ad873dd-d387-40c8-ae3c-1307d85d1c6a
https://research.vumc.nl/en/publications/4ad873dd-d387-40c8-ae3c-1307d85d1c6a
Autor:
De Haas, V., Kaspers, G. J.L., Oosten, L., Bresters, D., Pieters, R., Van Der Velden, V. H.J., Van Wering, E. R., Van Den Berg, H., Van Der Schoot, C. E.
Publikováno v:
De Haas, V, Kaspers, G J L, Oosten, L, Bresters, D, Pieters, R, Van Der Velden, V H J, Van Wering, E R, Van Den Berg, H & Van Der Schoot, C E 2002, ' Is there a relationship between in vitro drug resistance and level of minimal residual disease as detected by polymerase chain reaction at the end of induction therapy in childhood acute lymphoblastic leukaemia? [1] ', British Journal of Haematology, vol. 118, no. 4, pp. 1190-1191 . https://doi.org/10.1046/j.1365-2141.2002.36211.x
British Journal of Haematology, 118(4), 1190-1191. Wiley-Blackwell
British Journal of Haematology, 118(4), 1190-1191. Wiley-Blackwell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::a3c9d8c493e1742eeccb84065a0326b6
https://research.vumc.nl/en/publications/29bad8e6-bcb9-429f-a4c7-bf8e03a4400b
https://research.vumc.nl/en/publications/29bad8e6-bcb9-429f-a4c7-bf8e03a4400b
Publikováno v:
Medical and Pediatric Oncology, 37(6), 511-517
Background. Recently, the role of interleukin-8 (IL-8) in angiogenesis was reported. We consequently addressed here the question whether IL-8 produced by acute myeloid leukemia (AML) blasts might have a comparable function. Procedure. In 21 pediatric
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::3eb23305f6e18dcab0a0e6fdb71c6340
https://research.rug.nl/en/publications/41a6481a-fa42-4a59-b142-715270c7349a
https://research.rug.nl/en/publications/41a6481a-fa42-4a59-b142-715270c7349a
Autor:
Hb, Beverloo, Ioannis Panagopoulos, Isaksson M, van Wering E, van Drunen E, de Klein A, Johansson B, Slater R
Publikováno v:
Europe PubMed Central
Recently, we and others reported a recurrent t(7;12)(q36;p13) found in myeloid malignancies in childrenor =18 months of age and associated with a poor prognosis. Fluorescence in situ hybridization studies mapped the 12p13 breakpoint to the first intr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::8b40afd6df0e13f13b10988a875a2e25
https://pubmed.ncbi.nlm.nih.gov/11454678
https://pubmed.ncbi.nlm.nih.gov/11454678
Autor:
Beverloo, Berna, Panagopoulos, I, Isaksson, M, van Wering, E, Drunen, E, de Klein, A, Johansson, B, Slater, RM
Publikováno v:
Cancer Research, 61, 5374-5377. American Association for Cancer Research Inc.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::d071c296aea36bf33abad919b8243b78
https://pure.eur.nl/en/publications/78620502-b795-4084-8299-09050b3010ac
https://pure.eur.nl/en/publications/78620502-b795-4084-8299-09050b3010ac
Autor:
Zwaan, C. M., Kaspers, G. J.L., Pieters, R., Ramakers-Van Woerden, N. L., Den Boer, M. L., Wunsche, R., Rottier, M. M.A., Hahlen, K., Van Wering, E. R., Janka-Schaub, G. E., Creutzig, U., Veerman, A. J.P.
Publikováno v:
Zwaan, C M, Kaspers, G J L, Pieters, R, Ramakers-Van Woerden, N L, Den Boer, M L, Wunsche, R, Rottier, M M A, Hahlen, K, Van Wering, E R, Janka-Schaub, G E, Creutzig, U & Veerman, A J P 2000, ' Cellular drug resistance profiles in childhood acute myeloid leukemia : Differences between FAB types and comparison with acute lymphoblastic leukemia ', Blood, vol. 96, no. 8, pp. 2879-2886 .
Determining in vitro drug resistance may reveal clinically relevant information in childhood leukemia. Using the methylthiazol-tetrezolium assay, the resistance of untreated leukemic cells to 21 drugs was compared in 128 children with acute myeloid l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10172::aff6e18fcdbaede1579e5a9a0cec610b
https://research.vumc.nl/en/publications/2a693a95-f531-4569-a1a2-5d8297a1ddb8
https://research.vumc.nl/en/publications/2a693a95-f531-4569-a1a2-5d8297a1ddb8
Autor:
Hasle, H., Arico, M., Basso, G., Biondi, A., Cantu Rajnoldi, A., Creutzig, U., Fenu, S., Fonatsch, C., Haas, O. A., Harbott, J., Kardos, G., Kerndrup, G., Mann, G., Niemeyer, C. M., Ptoszkova, H., Ritter, J., Slater, R., Stary, J., Stollmann Gibbels, B., Testi, Anna Maria, Van Wering, E. R., Zimmermann, M.
Publikováno v:
Leukemia. 13(3)
We reviewed the clinical features, treatment, and outcome of 100 children with myelodysplastic syndrome (MDS), juvenile myelomonocytic leukemia (JMML), and acute myeloid leukemia (AML) associated with complete monosomy 7 (-7) or deletion of the long
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::7d087a0360326ac73b3f37a9a5cf680b
https://pubmed.ncbi.nlm.nih.gov/10086728
https://pubmed.ncbi.nlm.nih.gov/10086728
Autor:
Verhagen, O. J., Wijkhuijs, A. J., van der Sluijs-Gelling, A. J., Szczepański, T., van der Linden-Schrever, B. E., Pongers-Willemse, M. J., van Wering, E. R., van Dongen, J. J., van der Schoot, C. E.
Publikováno v:
Leukemia, 13(8), 1298-1299. Nature Publishing Group
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::c43389cc39a250b2f3d2858cd83f650f
https://pure.amc.nl/en/publications/suitable-dna-isolation-method-for-the-detection-of-minimal-residual-disease-by-pcr-techniques(feb64a7d-4da3-4222-819d-6e6f4e79a694).html
https://pure.amc.nl/en/publications/suitable-dna-isolation-method-for-the-detection-of-minimal-residual-disease-by-pcr-techniques(feb64a7d-4da3-4222-819d-6e6f4e79a694).html
Autor:
Cm, Niemeyer, Arico M, Basso G, Biondi A, Cantu Rajnoldi A, Creutzig U, Haas O, Harbott J, Henrik Hasle, Kerndrup G, Locatelli F, Mann G, Stollmann-Gibbels B, Veer-Korthof Et, T., van Wering E, Zimmermann M
Publikováno v:
Europe PubMed Central
Chronic myelomonocytic leukemia (CMML) is a rare hematopoietic malignancy of childhood. To define the clinical and hematologic characteristics of the disease, we performed a retrospective analysis of 110 children given the diagnosis CMML irrespective
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::da1f6348451e8d1b3fba97370113710c
https://pubmed.ncbi.nlm.nih.gov/9414312
https://pubmed.ncbi.nlm.nih.gov/9414312